Temporary immobile leaflet following transcatheter aortic valve replacement of a SAPIEN-XT valve
- 36 Downloads
Compliance with ethical standards
Conflict of interest
Hideki Ishii received lecture fees from Astellas Pharma Inc., Astrazeneca Inc., Daiichi-Sankyo Pharma Inc., and MSD K. K. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
The human subject has given informed consent and the authors have conformed to institutional guidelines.